Skip to main content
. 2019 Nov 14;38(1):11–19. doi: 10.1200/JCO.19.02107

FIG 1.

FIG 1.

Best percent change from baseline in target lesion size (RECIST version 1.1 by central review) by prior lines of therapy in patients with microsatellite instability–high colorectal cancer in (A) cohort A and (B) cohort B. (*) Two patients in cohort A did not have postbaseline assessments and are not included. (†) One patient in cohort B did not have postbaseline assessments and is not included.